Linperlisib Combined With Immunochemotherapy in Relapsed/Refractory LBCL
Clinical trial NCT06489808 · RECRUITING
Trial details
- NCT number
- NCT06489808
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-28
- Primary completion
- 2026-12-31
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.